Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...

On Monday, Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to ...

Cantor Fitzgerald started coverage on shares of Science Applications International (NYSE:SAIC – Free Report) in a research ...

Cantor Fitzgerald started coverage on shares of Amentum (NYSE:AMTM – Free Report) in a report issued on Friday, Marketbeat.com reports. The brokerage issued a neutral rating and a $25.00 target price ...

It’s not that the Trump administration is anti-Goldman Sachs, sources say, but rather there just isn’t as much talent to take ...

A U.S. Senate committee voted on Wednesday to advance President Donald Trump's nominee Howard Lutnick, billionaire chairman ...

Howard Lutnick, President Donald Trump's nominee for Commerce Secretary and CEO of Cantor Fitzgerald, says the firm has no ...

Cantor Fitzgerald analyst Thomas Blakey raised the firm’s price target on Cloudflare (NET) to $149 from $111 and keeps a Neutral rating on the ...

“As you can imagine, the pain we suffered with Gary and 657 of my other friends and colleagues at Cantor Fitzgerald were killed on 9/11,” Lutnick said during his confirmation hearing before ...

Cantor Fitzgerald analyst Colin Canfield initiated coverage of Amentum (AMTM) with a Neutral rating and $25 price target Maximize Your ...